NT-proBNP in patients with COVID-19
As a medical device manufacturer, Response Biomedical (RBM) has been closely monitoring the research regarding the detection of SARS-CoV-2.
September 16, 2021
Menu
News & Events
News
Point-of-Care Diagnostics in the Time of COVID-19: Challenges, Opportunities, and Perspectives
Since the onset of the pandemic, rapid testing has gone through many changes. Discover how POC testing has affected the healthcare system and what lies ahead.
July 12, 2021
What Is Rapid Testing? A Comprehensive Guide
Learn how rapid testing solutions have become a critical part of patient-centered care programs across the country. Our guide tells your everything you need to know, including how they work, their benefits, how accurate they are, and more.
June 10, 2021
RAMP COVID-19 Antigen Test Gets CE Mark
Response Biomedical launches COVID-19 (SARS-CoV-2) antigen test for countries accepting CE mark, to support the growing demand for testing. Response Biomedical Corp. (Response), a global
May 19, 2021
How COVID-19 Impacts Certain Biomarkers in Patients
As a medical device manufacturer, we have been closely monitoring the research that is currently being conducted into the detection of SARS-CoV-2. Response Biomedical’s purpose
September 1, 2020
Upcoming & Past Events
24 Hour Technical Support Available for all RAMP Customers
Contact Our Specialists
Start Testing Today
